Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tianbang Wu"'
Autor:
Hongrui Xu, Guolong Luo, Tianbang Wu, Jiankang Hu, Chao Wang, Xishan Wu, Yan Zhang, Yong Xu, Qiuping Xiang
Publikováno v:
Biochemical and Biophysical Research Communications. 623:17-22
Inhibition of the bromodomain of the CREB (cyclic-AMP response element-binding protein) binding protein (CBP) is a particularly promising new therapeutic approach for cancer. Benzimidazole derivatives CCS1477 and its analogues (8 and 9) are highly po
Autor:
Qiuping Xiang, Chao Wang, Tianbang Wu, Cheng Zhang, Qingqing Hu, Guolong Luo, Jiankang Hu, Xiaoxi Zhuang, Lingjiao Zou, Hui Shen, Xishan Wu, Yan Zhang, Xiangqian Kong, Jinsong Liu, Yong Xu
Publikováno v:
Journal of Medicinal Chemistry. 65:785-810
CREB (cyclic-AMP responsive element binding protein) binding protein (CBP) is a potential target for prostate cancer treatment. Herein, we report the structural optimization of a series of 1-(indolizin-3-yl)ethan-1-one compounds as new selective CBP
Publikováno v:
Applied Geography. 148:102789
Autor:
Qiuping Xiang, Guolong Luo, Cheng Zhang, Qingqing Hu, Chao Wang, Tianbang Wu, Hongrui Xu, Jiankang Hu, Xiaoxi Zhuang, Maofeng Zhang, Shuang Wu, Jinxin Xu, Yan Zhang, Jinsong Liu, Yong Xu
Publikováno v:
European Journal of Medicinal Chemistry. 236:114311
TRIM24 (tripartite motif-containing protein 24) and BRPF1 (bromodomain and PHD finger containing protein 1) are epigenetics "readers" and potential therapeutic targets for cancer and other diseases. Here we describe the structure-guided design of 1-(
Autor:
Qiuping Xiang, Chao Wang, Tianbang Wu, Cheng Zhang, Qingqing Hu, Guolong Luo, Jiankang Hu, Xiaoxi Zhuang, Lingjiao Zou, Hui Shen, Xishan Wu, Yan Zhang, Xiangqian Kong, Jinsong Liu, Yong Xu
Publikováno v:
Journal of Medicinal Chemistry; 1/13/2022, Vol. 65 Issue 1, p785-810, 26p